Latest news
CRBP (NASDAQ: CRBP) insider plans 12,000-share sale via Stifel - Stock TitanStock Titan · Fri, 07 Aug 2026 20:24:21 GMTCRBP (CRBP) holder files to sell 17,000 Nasdaq-traded shares - Stock TitanStock Titan · Fri, 07 Aug 2026 20:05:13 GMTCorbus Pharmaceuticals (NASDAQ: CRBP) doubles Q2 loss while securing FDA clearance for Phase 3 trial - Stock TitanStock Titan · Thu, 06 Aug 2026 12:15:45 GMTCorbus Pharmaceuticals Announces Last Patient Last Visit in CANYON-1 Study of CRB-913 for the Treatment of Obesity - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 12:30:00 GMTObesity Treatment Study Reaches Final Visit; Corbus Data Expected in September - Stock TitanStock Titan · Tue, 04 Aug 2026 12:30:00 GMTCSPC Pharmaceutical Group Limited Announces CRB-701 Receives U.S. FDA Clearance For Registrational Trial For Second-Line Treatment Of Oropharyngeal Cancer - marketscreener.commarketscreener.com · Wed, 29 Jul 2026 12:33:00 GMTCorbus Pharmaceuticals Announces FDA Clearance to Initiate - GlobeNewswireGlobeNewswire · Tue, 28 Jul 2026 12:00:00 GMT